Recommendation ID
IPG416/1
Question
Further research on the efficacy of deep brain stimulation (DBS) for refractory epilepsy should describe patient selection and define clearly the target area of the brain. Outcomes should include measures of seizure frequency, functional ability, social inclusion and quality of life.
Any explanatory notes
(if applicable)
The evidence on the efficacy of deep brain stimulation (DBS) for refractory epilepsy is limited in both quantity and quality. The evidence on safety shows that there are serious but well-known side effects. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.

Source guidance details

Comes from guidance
Deep brain stimulation for refractory epilepsy
Number
IPG416
Date issued
January 2012

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No